173 related articles for article (PubMed ID: 25640641)
1. Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption.
Feng R; Tong Q; Xie Z; Cheng H; Wang L; Lentzsch S; Roodman GD; Xie XQ
Mol Carcinog; 2015 Dec; 54(12):1796-806. PubMed ID: 25640641
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
Bettiga A; Aureli M; Colciago G; Murdica V; Moschini M; Lucianò R; Canals D; Hannun Y; Hedlund P; Lavorgna G; Colombo R; Bassi R; Samarani M; Montorsi F; Salonia A; Benigni F
Sci Rep; 2017 Feb; 7():42157. PubMed ID: 28191815
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29).
Alenabi A; Malekinejad H
Mol Cell Biochem; 2021 Sep; 476(9):3285-3301. PubMed ID: 33886060
[TBL] [Abstract][Full Text] [Related]
4. A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
Cioni C; Tassi M; Marotta G; Mugnaini C; Corelli F; Annunziata P
Cent Nerv Syst Agents Med Chem; 2019; 19(3):206-214. PubMed ID: 31549596
[TBL] [Abstract][Full Text] [Related]
5. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cannabinoid CB
Salort G; Álvaro-Bartolomé M; García-Sevilla JA
Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
[TBL] [Abstract][Full Text] [Related]
7. Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats.
Kim SD; Cho KJ; Kim JC
BMC Urol; 2017 Dec; 17(1):121. PubMed ID: 29284441
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
[TBL] [Abstract][Full Text] [Related]
9. Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells.
Capozzi A; Caissutti D; Mattei V; Gado F; Martellucci S; Longo A; Recalchi S; Manganelli V; Riitano G; Garofalo T; Sorice M; Manera C; Misasi R
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011295
[TBL] [Abstract][Full Text] [Related]
10. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
11. Direct Stimulatory Effects of the CB
Ruz-Maldonado I; Atanes P; Huang GC; Liu B; Persaud SJ
Cells; 2021 Mar; 10(3):. PubMed ID: 33809893
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists.
Yrjölä S; Sarparanta M; Airaksinen AJ; Hytti M; Kauppinen A; Pasonen-Seppänen S; Adinolfi B; Nieri P; Manera C; Keinänen O; Poso A; Nevalainen TJ; Parkkari T
Eur J Pharm Sci; 2015 Jan; 67():85-96. PubMed ID: 25447744
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo.
Barbado MV; Medrano M; Caballero-Velázquez T; Álvarez-Laderas I; Sánchez-Abarca LI; García-Guerrero E; Martín-Sánchez J; Rosado IV; Piruat JI; Gonzalez-Naranjo P; Campillo NE; Páez JA; Pérez-Simón JA
Int J Cancer; 2017 Feb; 140(3):674-685. PubMed ID: 27778331
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB
Li AL; Carey LM; Mackie K; Hohmann AG
J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
Xie J; Xiao D; Xu Y; Zhao J; Jiang L; Hu X; Zhang Y; Yu L
Oncotarget; 2016 Feb; 7(6):6436-47. PubMed ID: 26824325
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis.
Bilgic E; Guzel E; Kose S; Aydin MC; Karaismailoglu E; Akar I; Usubutun A; Korkusuz P
Acta Histochem; 2017 Jun; 119(5):523-532. PubMed ID: 28549792
[TBL] [Abstract][Full Text] [Related]
17. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells.
He F; Song ZH
Mol Vis; 2007 Jul; 13():1348-56. PubMed ID: 17679938
[TBL] [Abstract][Full Text] [Related]
19. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.
Sipe JC; Arbour N; Gerber A; Beutler E
J Leukoc Biol; 2005 Jul; 78(1):231-8. PubMed ID: 15845647
[TBL] [Abstract][Full Text] [Related]
20. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
